drugset / Trial / NCT02104050

Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain

NCT02104050 ↗

Phase 2 Completed 202 enrolled Olatec Therapeutics, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objectives of this trial are to investigate the efficacy and safety of six weeks of treatment with OLT1177 Gel in subjects with moderate to severe pain associated with osteoarthritis of the knee following cessation of pain therapy.

Timeline

Start
2014-04
Primary completion
2015-08
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Dapansutrile Small molecule 5 % Topical
Subject Dapansutrile Small molecule 6 ml Topical